Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatectomy × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1317 Neoplasms 1046 Carcinoma, Non-Small-Cell Lung 891 Prostatic Neoplasms 738 Lung Neoplasms 607 Colorectal Neoplasms 583 Neoplasm Metastasis 451 Multiple Myeloma 417 Leukemia, Myeloid, Acute 409 Ovarian Neoplasms 392 Pancreatic Neoplasms 346 Melanoma 342 Squamous Cell Carcinoma of Head and Neck 304 Recurrence 300 Carcinoma, Hepatocellular 295 Brain Neoplasms 291 Stomach Neoplasms 263 Glioblastoma 249 Head and Neck Neoplasms 242 Triple Negative Breast Neoplasms 236 Endometrial Neoplasms 228 Precursor Cell Lymphoblastic Leukemia-Lymphoma 227 Urinary Bladder Neoplasms 226 Uterine Cervical Neoplasms 225 Lymphoma 225 Carcinoma, Renal Cell 218 Glioma 202 Sarcoma 200 Colonic Neoplasms 200 Hematologic Neoplasms 199

Interventions

Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07507643 2026-04-02

A Study of Methylprednisolone in People Having Liver Surgery

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting

Hepatectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡